David Kingsley

Mr. David Kingsley


Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2019 in Acta Biomaterialia
Verified
Journal Article
Closed access
DKDavid Kingsley
David Kingsley
CRCassandra L. Roberge
Cassandra L. Roberge
ARAlena Rudkouskaya
Alena Rudkouskaya
DFDenzel E. Faulkner
Denzel E. Faulkner
MBMargarida Barroso
Margarida Barroso
DCDavid Corr
David Corr

24 April 2014 in Biosensors
Verified
Journal Article
Open access
PDF file
ADAndrew Dias
Andrew Dias
DKDavid Kingsley
David Kingsley
DCDavid Corr
David Corr
Future biosensing applications will require high performance, including real-time monitoring of physiological events, incorporation of biosensors into feedback-based devices, detection of toxins, and advanced diagnostics. Such functionality will necessitate biosensors with increased sensitivity, specificity, and throughput, as well as the ability to simultaneously detect multiple analytes. While these demands have yet to be fully realized, recent advances in biofabrication may allow sensors to achieve the high spatial sensitivity required, and bring us closer to achieving devices with these capabilities. To this end, we review recent advances in biofabrication techniques that may enable cutting-edge biosensors. In particular, we focus on bioprinting techniques (e.g., microcontact printing, inkjet printing, and laser direct-write) that may prove pivotal to biosensor fabrication and scaling. Recent biosensors have employed these fabrication techniques with success, and further development may enable higher performance, including multiplexing multiple analytes or cell types within a single biosensor. We also review recent advances in 3D bioprinting, and explore their potential to create biosensors with live cells encapsulated in 3D microenvironments. Such advances in biofabrication will expand biosensor utility and availability, with impact realized in many interdisciplinary fields, as well as in the clinic.

6 November 2013 in Biofabrication
Verified
Journal Article
Closed access
DKDavid Kingsley
David Kingsley
ADA D Dias
A D Dias
DCD B Chrisey
D B Chrisey
DCDavid Corr
David Corr
Alginate can be used to encapsulate mammalian cells and for the slow release of small molecules. Packaging alginate as microbead structures allows customizable delivery for tissue engineering, drug release, or contrast agents for imaging. However, state-of-the-art microbead fabrication has a limited range in achievable bead sizes, and poor control over bead placement, which may be desired to localize cellular signaling or delivery. Herein, we present a novel, laser-based method for single-step fabrication and precise planar placement of alginate microbeads. Our results show that bead size is controllable within 8%, and fabricated microbeads can remain immobilized within 2% of their target placement. Demonstration of this technique using human breast cancer cells shows that cells encapsulated within these microbeads survive at a rate of 89.6%, decreasing to 84.3% after five days in culture. Infusing rhodamine dye into microbeads prior to fluorescent microscopy shows their 3D spheroidal geometry and the ability to sequester small molecules. Microbead fabrication and patterning is compatible with conventional cellular transfer and patterning by laser direct-write, allowing location-based cellular studies. While this method can also be used to fabricate microbeads en masse for collection, the greatest value to tissue engineering and drug delivery studies and applications lies in the pattern registry of printed microbeads.

1 April 2019 in Journal of the Mechanical Behavior of Biomedical Materials
Verified
Journal Article
Closed access
DKDavid Kingsley
David Kingsley
CMCaitlin H. McCleery
Caitlin H. McCleery
CJChristopher D.L. Johnson
Christopher D.L. Johnson
MBMichael T.K. Bramson
Michael T.K. Bramson
DRDeniz Rende
Deniz Rende
DCDavid Corr
David Corr

29 September 2020 in Acta Biomaterialia
Verified
Journal Article
Closed access
CRCassandra L. Roberge
Cassandra L. Roberge
DKDavid Kingsley
David Kingsley
DFDenzel E. Faulkner
Denzel E. Faulkner
CSCharles J. Sloat
Charles J. Sloat
LWLing Wang
Ling Wang
DCDavid Corr
David Corr

13 April 2023 in Biofabrication
Verified
Journal Article
Closed access
VKVardhman Kumar
Vardhman Kumar
DKDavid Kingsley
David Kingsley
SPSajeeshkumar Madhurakkat Perikamana
Sajeeshkumar Madhurakkat Perikamana
PMPankaj Mogha
Pankaj Mogha
CGC Rory Goodwin
C Rory Goodwin
SVShyni Varghese
Shyni Varghese
Nociceptor sensory neurons play a key role in eliciting pain. An active crosstalk between nociceptor neurons and the vascular system at the molecular and cellular level is required to sense and respond to noxious stimuli. Besides nociception, interaction between nociceptor neurons and vasculature also contributes to neurogenesis and angiogenesis. In vitro models of innervated vasculature can greatly help delineate these roles while facilitating disease modeling and drug screening. Herein, we report the development of a microfluidic-assisted tissue model of nociception in the presence of microvasculature. The self-assembled innervated microvasculature was engineered using endothelial cells and primary dorsal root ganglion (DRG) neurons. The sensory neurons and the endothelial cells displayed distinct morphologies in presence of each other. The neurons exhibited an elevated response to capsaicin in the presence of vasculature. Concomitantly, increased transient receptor potential cation channel subfamily V member 1 (TRPV1) receptor expression was observed in the DRG neurons in presence of vascularization. Finally, we demonstrated the applicability of this platform for modeling nociception associated with tissue acidosis. While not demonstrated here, this platform could also serve as a tool to study pain resulting from vascular disorders while also paving the way towards the development of innervated microphysiological models.